CorMedix Inc.
CRMD
$10.32
$0.545.52%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 108.56M | 19.83M | 20.64M | 13.46M | -2.78M |
| Total Depreciation and Amortization | 3.79M | 162.90K | 161.90K | 133.70K | 77.40K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -55.85M | 2.71M | 3.55M | 1.37M | 1.26M |
| Change in Net Operating Assets | -25.65M | 7.29M | -4.62M | -20.58M | -12.22M |
| Cash from Operations | 30.86M | 29.99M | 19.74M | -5.61M | -13.65M |
| Capital Expenditure | -505.80K | -23.90K | -10.20K | -9.90K | -9.80K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -310.00M | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 19.19M | -20.19M | -184.60K | -294.30K | 6.33M |
| Cash from Investing | -291.32M | -20.21M | -194.80K | -304.20K | 6.32M |
| Total Debt Issued | 150.00M | -- | -- | -- | -- |
| Total Debt Repaid | -49.20K | -- | -- | -- | -- |
| Issuance of Common Stock | 1.33M | 83.49M | 7.11M | 11.34M | 14.07M |
| Repurchase of Common Stock | -464.10K | -247.50K | -1.02M | -53.00K | 0.00 |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -282.40K | -- | -- | -- | -- |
| Cash from Financing | 150.53M | 83.24M | 6.09M | 11.28M | 14.07M |
| Foreign Exchange rate Adjustments | 300.00 | 800.00 | 200.00 | -1.20K | 400.00 |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -109.93M | 93.02M | 25.63M | 5.36M | 6.75M |